Caligan Partners LP
13F Portfolio Filings
Most recent 13F
Q4 2024
Location
New York, NY
CIK
0001727492
All SEC filings
View on sec.gov
Holdings Value
Quarter
Holdings
Value ($000)
Top Holdings
Form Type
Date Filed
Filing ID
Q4 2024
14
394,876
LQDA, I9SA.HA, EXEL, EOLS
13F-HR
2/14/2025
000142050625000624
Q3 2024
12
315,472
LQDA, I9SA.HA, EXEL, EOLS
13F-HR
11/14/2024
000142050624002574
Q2 2024
13
427,996
LQDA, ALIM, ANIK, EXEL
13F-HR
8/14/2024
000181455424000010
Q1 2024
12
378,314
LQDA, ALIM, ANIK, EOLS
13F-HR
5/13/2024
000172749224000006
Q4 2023
11
296,522
LQDA, ALIM, ANIK, EXEL
13F-HR
2/14/2024
000172749224000002
Q3 2023
13
217,755
LQDA, ALIM, INTERCEPT PHARMACEUTICALS INC puts, LAB
13F-HR
11/14/2023
000172749223000011
Q2 2023
13
177,813
LQDA, ANIK, EXEL, LAB
13F-HR
8/14/2023
000172749223000009
Q1 2023
11
143,374
LQDA, ANIK, LAB, EXEL
13F-HR
5/15/2023
000181455423000002
Q4 2022
11
120,160
LQDA, ANIK, EOLS, ADMA
RESTATEMENT
5/15/2023
000181455423000005
Showing 1 to 9 of 9 entries
Previous
1
Next
Additional filings from Caligan Partners LP that have since been restated
Q4 2022